4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-000084
CEO acquired 35,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD CEO | 2024-12-30 | Option exercise | +35,000 | $0.60 | $21,000 | 96,885 | D |
| Derivatives | |||||||
| Kaye Edward M. MD CEO | 2024-12-30 | Option exercise · Employee Stock Option (Right to Buy) | −35,000 | 567,801 | D | ||
Loading xslF345X05/form4-01022025_090156.xml…